Value of Speckle Tracking Echocardiography Inflammatory Bowel Disease Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorAssiut University
About this trial
Value of speckle tracking echocardiography in early assessment of cardiac function in inflammatory bowel disease .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age (18-60) yrs.
Both sexes.
Patients with IBD either in active form or in remission.
Disqualifiers
Patients with ischemic heart disease. -Patients with other comorbidities affecting heart as uncontrolled hypertension or diabetes. -
Pregnant females.
Malignancy
Trial population
History: Demographic data; age, sex. History of the disease: onset, duration, medication. Family history of disease. History of comorbidities: hypertension, diabetes, ischemic heart diseases. Laboratory investigations: Fasting blood glucose, 2 hr postprandial and glycated haemoglobin A1c (HbA1c). Lipid profile: LDL, HDL, triglyceride, cholesterol. Inflammatory markers: CRP, ESR Complete blood picture Evaluation of Disease Severity Partial Mayo score consists three of the four components of the standard Mayo score, excluding endoscopic findings (stool frequency, rectal bleeding and physician's global assessment). Each component is assigned a score of 0-3, and total score ranges from 0 to 9 for each patient. -Echocardiographic Examination
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100 Participants
are grouped into 2 trial groupsGroup A: Study group adult with ulcerative colitis
Group B: control group
Trial outcomes
Primary outcomes
1
Subclincal cardiovascular events in IBD patients.
Assessment the predictive ability of Speckle TRACKING Echocardiograpy in development of subclinical cardiovascular events in IBD patients.
Time frame
through study completion, an average of 2 year2
Relation between isease activity and cardiac function
Evaluation of the relationship between disease activity and cardiac function as measured by Speckle tracking Echocardiograpy.
Time frame
through study completion, an average of 2 yearSecondary outcomes
1
correlation of Speckle TRACKING Echocardiograpy findings with traditional echocardiographic parameters
Detection of correlation of Speckle TRACKING Echocardiograpy findings with traditional echocardiographic parameters and inflammatory markers.
Time frame
through study completion, an average of 1 yearLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: